NCEP ATP III guidelines incorporate global risk assessment
Case reports illustrate consequences of ATP III in practice
Interview: Intergrating clinical trial results into managed care practice
Inflammatory markers are useful risk assessment tools
Atherosclerosis target of lipid-lowering therapy: Is Lower LDL cholesterol better?
IVUS is redefining atherosclerotic disease